Humoral Responses against BQ.1.1 Elicited after Breakthrough Infection and SARS-CoV-2 mRNA Vaccination

The Omicron BQ.1.1 variant is now the major SARS-CoV-2 circulating strain in many countries. Because of the many mutations present in its Spike glycoprotein, this variant is resistant to humoral responses elicited by monovalent mRNA vaccines. With the goal to improve immune responses against Omicron...

Descripción completa

Detalles Bibliográficos
Autores principales: Tauzin, Alexandra, Benlarbi, Mehdi, Medjahed, Halima, Grégoire, Yves, Perreault, Josée, Gendron-Lepage, Gabrielle, Gokool, Laurie, Morrisseau, Chantal, Arlotto, Pascale, Tremblay, Cécile, Kaufmann, Daniel E., Martel-Laferrière, Valérie, Levade, Inès, Côté, Marceline, De Serres, Gaston, Bazin, Renée, Finzi, Andrés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963157/
https://www.ncbi.nlm.nih.gov/pubmed/36851122
http://dx.doi.org/10.3390/vaccines11020242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963157/
https://www.ncbi.nlm.nih.gov/pubmed/36851122
http://dx.doi.org/10.3390/vaccines11020242

Ejemplares similares